Medical Malpractice Insurance News

While MLMIC can’t speak to the coverage of our competitors, we can assure our policyholders that MLMIC’s level of protection remains unchanged. We continue to provide exceptional coverage, a strong risk management program and high quality legal counsel.

MLMIC recognizes the “copy and paste” function of EHRs offers convenience and efficiency, but it also poses unique liability risks.

MLMIC posts information on its blog to assist policyholders in complying with the e-prescribing mandate. In addition, we want to share with you a new article about the challenges New York providers face regarding the pending implementation date.

MLMIC announces the appointment of Michael J. Schoppmann, Esq. as President of our service company subsidiary. Schoppmann’s long history of protecting doctors in New York State will contribute to the superior protection, sound defense and active risk management we offer all of our insureds.

The objective of the program is to prevent the improper procurement of prescriptions for controlled substances across state lines.

Applications for waivers to New York State’s mandatory electronic prescribing law are available ahead of the mandate’s March 27, 2016, start date.

MLMIC’s Board of Directors has approved a 20 percent dividend for all MLMIC policyholders.

In addition to concerns for potential contamination from airflow, excessive foot traffic may pose a risk for distraction of the OR staff.

Physicians and hospitals may be liable to the general public if a patient is not warned of medications that can impair the patient’s driving ability. A third party who is injured in an accident may now sue the physician or hospital directly if there has been a failure to warn the patient of the side effects.

Medscape data offers some perspective related to medical liability and malpractice litigation.